Clinical Trial Update: Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease [EARLY_Phase 1]

View source ↗

Summary

Massachusetts General Hospital is conducting an early-phase 1 trial of transcranial magnetic stimulation for Alzheimer's disease and related cognitive condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Logopenic Variant Primary Progressive Aphasia

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Alzheimer Disease, Mild Cognitive Impairment | EARLY_Phase 1 | Status: RECRUITING